Symbols / TXMD
TXMD Chart
About
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 26.04M |
| Enterprise Value | 25.41M | Income | 73.00K | Sales | 2.80M |
| Book/sh | 2.37 | Cash/sh | 0.61 | Dividend Yield | — |
| Payout | 0.00% | Employees | 1 | IPO | — |
| P/E | 225.00 | Forward P/E | 6.43 | PEG | — |
| P/S | 9.31 | P/B | 0.95 | P/C | — |
| EV/EBITDA | -19.21 | EV/Sales | 9.09 | Quick Ratio | 2.18 |
| Current Ratio | 2.93 | Debt/Eq | 23.62 | LT Debt/Eq | — |
| EPS (ttm) | 0.01 | EPS next Y | 0.35 | EPS Growth | — |
| Revenue Growth | 43.30% | Earnings | 2023-08-14 07:00 | ROA | -2.73% |
| ROE | 0.27% | ROIC | — | Gross Margin | 100.00% |
| Oper. Margin | -37.76% | Profit Margin | 10.80% | Shs Outstand | 11.57M |
| Shs Float | 9.56M | Short Float | 0.56% | Short Ratio | 0.29 |
| Short Interest | — | 52W High | 2.95 | 52W Low | 0.72 |
| Beta | 0.52 | Avg Volume | 93.66K | Volume | 22.05K |
| Target Price | — | Recom | None | Prev Close | $2.25 |
| Price | $2.25 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.25
Latest analyst target
3. DCF / Fair value
$-2.17
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.25
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-08-17 | reit | Cantor Fitzgerald | Neutral → Neutral | $5 |
| 2022-07-13 | reit | Cantor Fitzgerald | — → Neutral | $1 |
| 2022-06-07 | down | HC Wainwright & Co. | Buy → Neutral | $10 |
- How Low Can TherapeuticsMD Stock Really Go? - Trefis Sun, 21 Dec 2025 08
- TXMD Shares Surge on Strategic Developments - StocksToTrade Sat, 18 Oct 2025 07
- TherapeuticsMD Swings to Profit in Q2 - Nasdaq ue, 12 Aug 2025 07
- TXMD Stock Rallies After Strategic Agreement in Europe - StocksToTrade Sun, 19 Oct 2025 07
- TXMD’s Latest Strategic Moves Elevate Market Position - timothysykes.com Sun, 19 Oct 2025 07
- TherapeuticsMD (NASDAQ:TXMD) investors are sitting on a loss of 90% if they invested five years ago - Yahoo Finance Wed, 24 Nov 2021 08
- TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch ue, 25 Mar 2025 07
- TherapeuticsMD: From Fallen And Forgotten To Cash Cow - Seeking Alpha ue, 23 May 2023 07
- TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024 - InvestorPlace Mon, 12 Aug 2024 07
- TXMD Stock Price and Chart — NASDAQ:TXMD - TradingView ue, 10 Oct 2017 22
- Introducing TherapeuticsMD (NASDAQ:TXMD), The Stock That Slid 63% In The Last Three Years - Yahoo Finance Fri, 22 Nov 2019 08
- TherapeuticsMD, Inc. (TXMD) Q1 2022 Earnings Call Transcript - The Motley Fool Mon, 16 May 2022 07
- TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch Mon, 03 Mar 2025 08
- Here's Why TherapeuticsMD Stock Is Rocketing Higher Today - The Motley Fool Wed, 29 Apr 2020 07
- Why TherapeuticsMD Shares Are Sinking Today? - Yahoo Finance Wed, 13 Jul 2022 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 8400 | 14031.0 | — | Purchase at price 1.67 per share. | THOMPSON TOMMY G | Director | — | 2025-12-23 00:00:00 | D |
| 1 | 490 | 489.0 | — | Purchase at price 1.00 per share. | WALKER MARLAN D | Chief Executive Officer | — | 2025-04-14 00:00:00 | D |
| 2 | 325 | 326.0 | — | Purchase at price 1.00 per share. | THOMPSON TOMMY G | Director | — | 2025-04-14 00:00:00 | D |
| 3 | 2303 | 1994.0 | — | Purchase at price 0.86 - 0.87 per share. | WALKER MARLAN D | Chief Executive Officer | — | 2025-04-10 00:00:00 | D |
| 4 | 8281 | nan | — | — | WALKER MARLAN D | Chief Executive Officer | — | 2025-02-18 00:00:00 | D |
| 5 | 8500 | nan | — | — | NAUGHTON GAIL K | Director | — | 2025-02-18 00:00:00 | D |
| 6 | 8500 | nan | — | — | THOMPSON TOMMY G | Director | — | 2025-02-18 00:00:00 | D |
| 7 | 8500 | nan | — | — | COLLINS COOPER C | Director | — | 2025-02-18 00:00:00 | D |
| 8 | 4094 | 7099.0 | — | Purchase at price 1.73 per share. | COLLINS COOPER C | Director | — | 2024-08-22 00:00:00 | D |
| 9 | 1200 | 2039.0 | — | Purchase at price 1.70 per share. | COLLINS COOPER C | Director | — | 2024-08-21 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -16.48K | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.01 | 0.01 | 0.00 | 0.00 |
| NormalizedEBITDA | -1.72M | -7.60M | 21.34M | -78.84M |
| TotalUnusualItems | -1.27M | 0.00 | -9.47M | 0.00 |
| TotalUnusualItemsExcludingGoodwill | -1.27M | 0.00 | -9.47M | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -2.31M | -7.70M | 1.07M | -79.31M |
| ReconciledDepreciation | 509.00K | 922.00K | 1.20M | 736.00K |
| ReconciledCostOfRevenue | 22.00K | 1.39M | 1.40M | |
| EBITDA | -2.98M | -7.60M | 11.86M | -78.84M |
| EBIT | -3.49M | -8.52M | 10.66M | -79.58M |
| NetInterestIncome | -32.92M | |||
| InterestExpense | 22.57M | |||
| NormalizedIncome | -1.06M | -7.70M | 10.55M | -79.31M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -2.18M | -10.28M | 112.00M | -172.41M |
| TotalExpenses | 5.25M | 9.82M | 59.30M | 82.15M |
| TotalOperatingIncomeAsReported | -4.76M | -8.52M | 1.19M | -79.58M |
| DilutedAverageShares | 11.53M | 10.44M | 9.37M | 7.96M |
| BasicAverageShares | 11.53M | 10.44M | 9.03M | 7.96M |
| DilutedEPS | -0.19 | -0.98 | 11.96 | -21.50 |
| BasicEPS | -0.19 | -0.98 | 12.41 | -21.50 |
| DilutedNIAvailtoComStockholders | -2.18M | -10.28M | 112.00M | -172.41M |
| NetIncomeCommonStockholders | -2.18M | -10.28M | 112.00M | -172.41M |
| NetIncome | -2.18M | -10.28M | 112.00M | -172.41M |
| NetIncomeIncludingNoncontrollingInterests | -2.18M | -10.28M | 112.00M | -172.41M |
| NetIncomeDiscontinuousOperations | 131.00K | -2.58M | 110.92M | -93.11M |
| NetIncomeContinuousOperations | -2.31M | -7.70M | 1.07M | -79.31M |
| TaxProvision | -31.00K | -43.00K | 0.00 | 0.00 |
| PretaxIncome | -2.34M | -7.74M | 1.07M | -79.31M |
| OtherIncomeExpense | 1.15M | 781.00K | -9.59M | 272.00K |
| OtherNonOperatingIncomeExpenses | 2.42M | 781.00K | -117.00K | 272.00K |
| SpecialIncomeCharges | -1.27M | 0.00 | -9.47M | 0.00 |
| ImpairmentOfCapitalAssets | 1.27M | 0.00 | ||
| RestructuringAndMergernAcquisition | 0.00 | 9.47M | 0.00 | |
| NetNonOperatingInterestIncomeExpense | -32.92M | |||
| TotalOtherFinanceCost | 10.35M | |||
| InterestExpenseNonOperating | 22.57M | |||
| OperatingIncome | -3.49M | -8.52M | 10.66M | -79.58M |
| OperatingExpense | 5.25M | 9.82M | 57.90M | 80.75M |
| DepreciationAmortizationDepletionIncomeStatement | 509.00K | 922.00K | 1.19M | |
| DepreciationAndAmortizationInIncomeStatement | 509.00K | 922.00K | 1.19M | |
| ResearchAndDevelopment | 0.00 | 0.00 | ||
| SellingGeneralAndAdministration | 4.74M | 8.90M | 56.71M | 80.75M |
| SellingAndMarketingExpense | 0.00 | 0.00 | ||
| GeneralAndAdministrativeExpense | 57.90M | 80.75M | ||
| OtherGandA | 57.90M | 80.75M | ||
| GrossProfit | 1.30M | 68.57M | 1.17M | |
| CostOfRevenue | 0.00 | 1.40M | 1.40M | |
| TotalRevenue | 1.76M | 1.30M | 69.96M | 2.57M |
| OperatingRevenue | 1.76M | 1.30M | 69.96M | 2.57M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 11.53M | 11.53M | 9.50M | 8.60M |
| ShareIssued | 11.53M | 11.53M | 9.50M | 8.60M |
| NetDebt | 123.36M | |||
| TotalDebt | 7.17M | 8.01M | 8.76M | 197.69M |
| TangibleBookValue | 23.05M | 23.19M | 28.20M | -100.77M |
| InvestedCapital | 27.37M | 29.29M | 35.14M | 94.65M |
| WorkingCapital | 7.09M | 4.94M | 8.51M | -133.42M |
| NetTangibleAssets | 23.05M | 23.19M | 28.20M | -100.77M |
| CapitalLeaseObligations | 7.17M | 8.01M | 8.76M | 9.42M |
| CommonStockEquity | 27.37M | 29.29M | 35.14M | -93.62M |
| TotalCapitalization | 27.37M | 29.29M | 35.14M | -93.62M |
| TotalEquityGrossMinorityInterest | 27.37M | 29.29M | 35.14M | -93.62M |
| StockholdersEquity | 27.37M | 29.29M | 35.14M | -93.62M |
| RetainedEarnings | -951.82M | -949.64M | -939.36M | -1.05B |
| AdditionalPaidInCapital | 979.18M | 978.92M | 974.50M | 957.73M |
| CapitalStock | 11.00K | 11.00K | 9.00K | 9.00K |
| CommonStock | 11.00K | 11.00K | 9.00K | 9.00K |
| PreferredStock | 0.00 | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 11.45M | 14.02M | 55.31M | 263.09M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 6.29M | 7.17M | 8.48M | 10.20M |
| OtherNonCurrentLiabilities | 744.00K | 636.00K | 1.11M | 2.14M |
| LongTermDebtAndCapitalLeaseObligation | 5.54M | 6.53M | 7.37M | 8.06M |
| LongTermCapitalLeaseObligation | 5.54M | 6.53M | 7.37M | 8.06M |
| CurrentLiabilities | 5.17M | 6.85M | 46.84M | 252.89M |
| OtherCurrentLiabilities | 2.78M | 3.69M | 25.83M | 47.91M |
| CurrentDeferredLiabilities | 0.00 | 1.01M | 0.00 | |
| CurrentDebtAndCapitalLeaseObligation | 1.63M | 1.47M | 1.39M | 189.63M |
| CurrentCapitalLeaseObligation | 1.63M | 1.47M | 1.39M | 1.36M |
| CurrentDebt | 188.27M | |||
| OtherCurrentBorrowings | 188.27M | |||
| PayablesAndAccruedExpenses | 752.00K | 1.69M | 18.61M | 15.35M |
| CurrentAccruedExpenses | 494.00K | 1.66M | 16.45M | 11.98M |
| Payables | 258.00K | 27.00K | 2.16M | 3.37M |
| AccountsPayable | 258.00K | 27.00K | 2.16M | 3.37M |
| TotalAssets | 38.82M | 43.31M | 90.46M | 169.47M |
| TotalNonCurrentAssets | 26.56M | 31.51M | 35.11M | 50.00M |
| OtherNonCurrentAssets | 130.00K | 58.00K | 253.00K | 33.80M |
| NonCurrentAccountsReceivable | 16.01M | 18.48M | 20.25M | |
| GoodwillAndOtherIntangibleAssets | 4.32M | 6.10M | 6.94M | 7.14M |
| OtherIntangibleAssets | 4.32M | 6.10M | 6.94M | 7.14M |
| NetPPE | 6.10M | 6.87M | 7.66M | 9.06M |
| AccumulatedDepreciation | -2.52M | -2.44M | -1.97M | |
| GrossPPE | 6.10M | 6.87M | 10.10M | 11.03M |
| Leases | 49.00K | 49.00K | 80.00K | |
| OtherProperties | 6.10M | 6.87M | 7.58M | 8.23M |
| MachineryFurnitureEquipment | 2.47M | 2.47M | 2.71M | |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 12.26M | 11.80M | 55.35M | 119.47M |
| OtherCurrentAssets | 3.64M | 4.04M | 6.03M | 3.56M |
| AssetsHeldForSaleCurrent | 0.00 | 344.00K | 0.00 | 48.70M |
| RestrictedCash | 0.00 | 11.25M | 0.00 | |
| PrepaidAssets | 253.00K | 1.17M | 2.30M | |
| Inventory | 7.62M | |||
| FinishedGoods | 2.94M | |||
| WorkInProcess | 1.64M | |||
| RawMaterials | 3.04M | |||
| Receivables | 3.56M | 3.09M | 0.00 | 36.18M |
| OtherReceivables | 3.56M | 3.09M | ||
| AccountsReceivable | 36.18M | |||
| AllowanceForDoubtfulAccountsReceivable | -1.33M | |||
| GrossAccountsReceivable | 37.51M | |||
| CashCashEquivalentsAndShortTermInvestments | 5.06M | 4.33M | 38.07M | 64.91M |
| CashAndCashEquivalents | 5.06M | 4.33M | 38.07M | 64.91M |
| CashFinancial | 38.07M | 64.91M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 1.17M | -23.08M | 9.00M | -144.92M |
| RepurchaseOfCapitalStock | 0.00 | -38.66M | 0.00 | |
| RepaymentOfDebt | 0.00 | -219.43M | -50.00M | |
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 0.00 | 3.15M | 24.15M | 184.35M |
| CapitalExpenditure | -355.00K | -2.22M | ||
| InterestPaidSupplementalData | 0.00 | 13.54M | 25.07M | |
| EndCashPosition | 5.06M | 4.33M | 49.32M | 65.12M |
| BeginningCashPosition | 4.33M | 49.32M | 65.12M | 80.49M |
| ChangesInCash | 732.00K | -44.99M | -15.80M | -15.36M |
| CashFlowFromDiscontinuedOperation | -438.00K | -25.06M | 210.40M | |
| FinancingCashFlow | 0.00 | 3.15M | -235.21M | 129.55M |
| CashFromDiscontinuedFinancingActivities | 0.00 | 0.00 | ||
| CashFlowFromContinuingFinancingActivities | 0.00 | 3.15M | -235.21M | 129.55M |
| NetOtherFinancingCharges | -1.27M | -5.12M | ||
| ProceedsFromStockOptionExercised | 0.00 | 322.00K | ||
| NetPreferredStockIssuance | 0.00 | -16.97M | 0.00 | |
| PreferredStockPayments | 0.00 | -38.66M | 0.00 | |
| PreferredStockIssuance | 0.00 | 21.68M | 0.00 | |
| NetCommonStockIssuance | 0.00 | 3.15M | 2.47M | 184.35M |
| CommonStockIssuance | 0.00 | 3.15M | 2.47M | 184.35M |
| NetIssuancePaymentsOfDebt | 0.00 | -219.43M | -50.00M | |
| NetShortTermDebtIssuance | -219.43M | -50.00M | ||
| ShortTermDebtPayments | -219.43M | -50.00M | ||
| NetLongTermDebtIssuance | 0.00 | -219.43M | 0.00 | |
| LongTermDebtPayments | 0.00 | -219.43M | -50.00M | |
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | 0.00 | -355.00K | -2.22M | |
| CashFromDiscontinuedInvestingActivities | 223.83M | 0.00 | ||
| CashFlowFromContinuingInvestingActivities | 0.00 | -355.00K | -2.22M | |
| NetIntangiblesPurchaseAndSale | 0.00 | -355.00K | -2.19M | |
| PurchaseOfIntangibles | -355.00K | -2.19M | ||
| NetPPEPurchaseAndSale | 0.00 | -34.00K | ||
| PurchaseOfPPE | 0.00 | -34.00K | ||
| OperatingCashFlow | 1.17M | -23.08M | 9.36M | -142.69M |
| CashFromDiscontinuedOperatingActivities | -13.44M | -87.56M | ||
| CashFlowFromContinuingOperatingActivities | 1.17M | -23.08M | 9.37M | -55.13M |
| ChangeInWorkingCapital | 1.66M | -17.45M | -4.09M | 4.59M |
| ChangeInOtherCurrentLiabilities | 108.00K | -471.00K | -121.00K | 2.14M |
| ChangeInOtherCurrentAssets | 1.93M | -1.13M | -7.64M | 0.00 |
| ChangeInPayablesAndAccruedExpense | -775.00K | -17.85M | 3.05M | 3.58M |
| ChangeInAccruedExpense | -1.01M | -15.71M | 4.26M | 4.64M |
| ChangeInPayable | 231.00K | -2.13M | -1.21M | -1.06M |
| ChangeInAccountPayable | 231.00K | -2.13M | -1.21M | -1.06M |
| ChangeInPrepaidAssets | 397.00K | 2.00M | 620.00K | -1.12M |
| ChangeInInventory | -711.00K | |||
| ChangeInReceivables | -4.33M | |||
| ChangesInAccountReceivables | -4.33M | |||
| OtherNonCashItems | -219.00K | -129.00K | -401.00K | 720.00K |
| StockBasedCompensation | 264.00K | 1.27M | 11.57M | 18.12M |
| ProvisionandWriteOffofAssets | 533.00K | |||
| AssetImpairmentCharge | 1.27M | 0.00 | 0.00 | |
| DepreciationAmortizationDepletion | 509.00K | 922.00K | 1.20M | 736.00K |
| DepreciationAndAmortization | 509.00K | 922.00K | 1.20M | 736.00K |
| AmortizationCashFlow | 800.00K | 600.00K | ||
| AmortizationOfIntangibles | 800.00K | 600.00K | ||
| Depreciation | 100.00K | 600.00K | ||
| NetIncomeFromContinuingOperations | -2.31M | -7.70M | 1.07M | -79.31M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for TXMD
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|